TREM2 and Alzheimer disease: So far, in humans, no variant is known that exclusively leads to soluble TREM2 expression, but a shedding enhancing cleavage site mutation has been described (H157Y) that is associated with AD increasing soluble TREM2 and reducing functional membrane TREM2 by approx. 50% [26].